439 related articles for article (PubMed ID: 1924393)
41. Activation of MHC class I-restricted CD8+ CTL by microbial T cell mitogens. Dependence upon MHC class II expression of the target cells and V beta usage of the responder T cells.
Herrmann T; Maryanski JL; Romero P; Fleischer B; MacDonald HR
J Immunol; 1990 Feb; 144(4):1181-6. PubMed ID: 1968075
[TBL] [Abstract][Full Text] [Related]
42. Reactivity of human gamma delta T cells to staphylococcal enterotoxins: a restricted reaction pattern mediated by two distinct recognition pathways.
Rust C; Orsini D; Kooy Y; Koning F
Scand J Immunol; 1993 Jul; 38(1):89-94. PubMed ID: 8327863
[TBL] [Abstract][Full Text] [Related]
43. Identification of HLA-DR1 beta chain residues critical for binding staphylococcal enterotoxins A and E.
Karp DR; Long EO
J Exp Med; 1992 Feb; 175(2):415-24. PubMed ID: 1370684
[TBL] [Abstract][Full Text] [Related]
44. Direct binding of secreted T-cell receptor beta chain to superantigen associated with class II major histocompatibility complex protein.
Gascoigne NR; Ames KT
Proc Natl Acad Sci U S A; 1991 Jan; 88(2):613-6. PubMed ID: 1824876
[TBL] [Abstract][Full Text] [Related]
45. Staphylococcal enterotoxins direct and trigger CTL killing of autologous HLA-DR+ mononuclear leukocytes and freshly prepared leukemia cells.
Hedlund G; Dohlsten M; Lando PA; Kalland T
Cell Immunol; 1990 Sep; 129(2):426-34. PubMed ID: 2383900
[TBL] [Abstract][Full Text] [Related]
46. Concomitant Disruption of
Chowdhary VR; Krogman A; Tilahun AY; Alexander MP; David CS; Rajagopalan G
J Immunol; 2017 Jun; 198(11):4413-4424. PubMed ID: 28468970
[TBL] [Abstract][Full Text] [Related]
47. Immunopharmacology of the superantigen staphylococcal enterotoxin A in T-cell receptor V beta 3 transgenic mice.
Dohlsten M; Björklund M; Sundstedt A; Hedlund G; Samson D; Kalland T
Immunology; 1993 Aug; 79(4):520-7. PubMed ID: 7691731
[TBL] [Abstract][Full Text] [Related]
48. Endothelial cells expressing an inflammatory phenotype are lysed by superantigen-targeted cytotoxic T cells.
Riesbeck K; Billström A; Tordsson J; Brodin T; Kristensson K; Dohlsten M
Clin Diagn Lab Immunol; 1998 Sep; 5(5):675-82. PubMed ID: 9729535
[TBL] [Abstract][Full Text] [Related]
49. Vaccination with IL-18 gene-modified, superantigen-coated tumor cells elicits potent antitumor immune response.
Wang Q; Yu H; Zhang L; Ju D; Pan J; Xia D; He L; Wang J; Cao X
J Cancer Res Clin Oncol; 2001 Dec; 127(12):718-26. PubMed ID: 11768611
[TBL] [Abstract][Full Text] [Related]
50. Antigen-presenting T cells induce the development of cytotoxic CD4+ T cells. I. Involvement of the CD80-CD28 adhesion molecules.
Mauri D; Wyss-Coray T; Gallati H; Pichler WJ
J Immunol; 1995 Jul; 155(1):118-27. PubMed ID: 7541409
[TBL] [Abstract][Full Text] [Related]
51. Antibody-targeted superantigens are potent inducers of tumor-infiltrating T lymphocytes in vivo.
Dohlsten M; Hansson J; Ohlsson L; Litton M; Kalland T
Proc Natl Acad Sci U S A; 1995 Oct; 92(21):9791-5. PubMed ID: 7568219
[TBL] [Abstract][Full Text] [Related]
52. Gamma delta T cell reactivity towards bacterial superantigens.
Rust CJ; Koning F
Semin Immunol; 1993 Feb; 5(1):41-6. PubMed ID: 8467094
[TBL] [Abstract][Full Text] [Related]
53. Monoclonal antibodies defining functional sites on the toxin superantigen staphylococcal enterotoxin B.
Hamad AR; Herman A; Marrack P; Kappler JW
J Exp Med; 1994 Aug; 180(2):615-21. PubMed ID: 7519243
[TBL] [Abstract][Full Text] [Related]
54. Superantigen-induced human CD4+ helper/killer T cell phenomenon. Selective induction of Th1 helper/killer T cells and application to tumor immunotherapy.
Kuge S; Miura Y; Nakamura Y; Mitomi T; Habu S; Nishimura T
J Immunol; 1995 Feb; 154(4):1777-85. PubMed ID: 7836762
[TBL] [Abstract][Full Text] [Related]
55. Superantigens: interaction of staphylococcal enterotoxins with MHC class II molecules.
Rich RR; Mollick JA; Cook RG
Trans Am Clin Climatol Assoc; 1990; 101():195-204; discussion 204-6. PubMed ID: 2577245
[TBL] [Abstract][Full Text] [Related]
56. Human intestinal V delta 1+ T cells obtained from patients with colon cancer respond exclusively to SEB but not to SEA.
Maeurer M; Zitvogel L; Elder E; Storkus WJ; Lotze MT
Nat Immun; 1995 Apr; 14(4):188-97. PubMed ID: 8696008
[TBL] [Abstract][Full Text] [Related]
57. Major histocompatibility complex class I-specific and -restricted killing of beta 2-microglobulin-deficient cells by CD8+ cytotoxic T lymphocytes.
Glas R; Franksson L; Ohlén C; Höglund P; Koller B; Ljunggren HG; Kärre K
Proc Natl Acad Sci U S A; 1992 Dec; 89(23):11381-5. PubMed ID: 1454824
[TBL] [Abstract][Full Text] [Related]
58. Antibody-directed superantigen-mediated T-cell killing of myeloid leukaemic cell line cells.
Gidlöf C; Carlson B; Dohlsten M; Tötterman TH
Eur J Haematol; 1998 Apr; 60(4):233-9. PubMed ID: 9579876
[TBL] [Abstract][Full Text] [Related]
59. Variable influence of MHC polymorphism on the recognition of bacterial superantigens by T cells.
Wen R; Blackman MA; Woodland DL
J Immunol; 1995 Aug; 155(4):1884-92. PubMed ID: 7636239
[TBL] [Abstract][Full Text] [Related]
60. Immunotherapy of human colon cancer by antibody-targeted superantigens.
Dohlsten M; Lando PA; Björk P; Abrahmsén L; Ohlsson L; Lind P; Kalland T
Cancer Immunol Immunother; 1995 Sep; 41(3):162-8. PubMed ID: 7553685
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
